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As long as I can remember, I wanted a career in the healthcare field. However, I was 
unsure of my specific place in the industry. All I knew is that I wanted to make healthcare 
better. I discovered quality improvement methodologies (Certified Six Sigma Black Belt) and 
project management tools (Project Management Professional). Through my experience and 
web-based technologies, I became proficient at implementing change across institutions in 
geographically disperse locations.  
I took an interest in Hospital Engagement Networks during their final year of 
implementation, 2014. I was caught up in the debate on whether large-scale quality 
improvement collaborations were effective at driving large-scale change. Simultaneously, I 
was perplexed with the lack of technology behind the HEN program’s implementation 
strategy and methodology.  
It is now five years since the first HEN program’s completion, and to my knowledge, 
there have been no peer-reviewed articles evaluating the effectiveness of the HEN program 
compared to nonparticipants. Through my dissertation research, I hoped to understand 
whether the HEN programs were successful and how such large-scale quality improvement 
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In 2012, the Centers for Medicare and Medicaid Services (CMS) launched the 
Hospital Engagement Network (HEN) program to decrease patient harm events in United 
States’ (US) hospitals. The HEN program became the nation’s largest quality improvement 
collaborative (QIC) focusing on improving patient care. Results from the program’s formal 
evaluation were inconclusive on whether the HEN program was effective. There have been 
no other known studies on this program’s effectiveness. Even with the evidence lacking, the 
CMS continues to fund programs similar to the HEN program. This study’s research aim was 
to compare patient outcomes for HEN participants to nonparticipants to evaluate the 
program’s performance.  
The sample contained US hospitals with at least 25 beds and reported outcome data to 
Hospital Compare. A retrospective comparative analysis was performed on central line-
associated bloodstream infection (CLABSI) standardized infection ratios (SIRs) and 30-day 





In both articles, pre-post trends were analyzed using fixed effects regression models to 
control for hospital characteristics and baseline performance. 
For the first study, there were a total of 7,632 hospital years of data between HEN 
participants (6,374) and nonparticipants (1,258). The fixed effects regression model indicated 
that HEN participation did not reduce the CLABSI SIR in participating hospitals (p=.816). 
When the sample was divided into three groups based on baseline performance, the HEN 
participation coefficient (-.085) was moderately significant (p=.079) for the high performing 
group (lowest average CLASBI SIR in 2011). For the other two groups, medium (p=.960) 
and low performance (p=.848), the HEN participating coefficient was not significant. 
The second study was based on a total 76,900 hospital years of data with 30-day 
readmission rates for HF (28,280), AMI (20,936), pneumonia (27,684). The pre-post fixed 
effect regression coefficients for HEN participation were varied for HF (.018, p=.639), AMI 
(-.073, p=.032), and pneumonia (.097, p=.003). When using full panel data, the fixed effect 
regression coefficients were similar to the original sample with 30-day readmission rates for 
HF(-.032, p=.439), AMI (-.148, p=.001), and pneumonia (.103, p=.014). The sensitivity 
analysis determined that HEN participants achieved superior AMI readmission 
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Patient harm events continue to be a persistent issue in the United States (US). The 
Institute of Medicine (IOM), now the Health and Medicine Division of the National 
Academies of Sciences, stated in its ground-breaking report that 44,000-98,000 patients die 
every year from medical harm events.1 More recent studies have shown the patient harm 
events are still prevalent with little improvement.2 These patient harm incidents include 
hospital-acquired conditions and associated readmissions. A hospital-acquired condition is a 
condition that presents during a hospital stay that was not present on admission.3 The total 
cost of patient harm events in the US ranges between $17.1 billion4 and $19 billion.5  
Hospital Engagement Networks 
 
In 2001, the IOM recommended that the US should invest in a $1 billion, three-to-
five-year national patient safety initiative to catalyze a national safety movement.6 In 2010, 
the Patient Protection and Affordable Care Act (ACA) commissioned the Department of 
Health and Human Services (HHS) to develop a national strategy for improving patient 
outcomes.7 In 2011, HHS launched the Partnership for Patients (PfP) initiative with a $1 
billion budget to reduce preventable hospital-acquired conditions by 40% and readmissions 
by 20%.8,9   
The PfP initiative allocated $218 million to develop the Hospital Engagement 
Network (HEN) program.8 The HEN program designated 26 organizations as “Hospital 




HEN organizations ranged from state hospital associations to public, for-profit companies. 
They were able to recruit over 3,700 hospitals to join their programs.10  
The HENs were responsible for improving eleven patient harm events: central line-
associated bloodstream infections (CLABSIs), adverse drug events, catheter-associated 
urinary tract infections (CAUTIs), injuries from falls, pressure ulcers, obstetrical adverse 
events, surgical site infections, venous thromboembolism, ventilator-associated pneumonia, 
preventable readmissions, and early elective deliveries.8 In addition to focusing on these 
patient harm areas, the HENs were tasked with decreasing 30-day all-cause readmission rates 
by 20%.  
While implementation models varied across the HENs, the American Hospital 
Association (AHA) recommended four improvement tactics: 
1. Facilitate training through a combination of face-to-face meetings and webinars (with replay 
opportunities), monthly coaching calls, and hold quarterly individual calls with each participating 
hospital to provide assistance gauge implementation process, identify barriers and successes and to 
direct development of additional supporting resources  
2. Require hospitals to report process measures to assure implementation of key process changes, and 
benchmark progress  
3. Provide technical assistance when triggers are hit (outliers based on data)  
4. Leadership Engagement and support of unit-level activities and needs to include rounding, 
understanding of data and regular reporting to Board and hospital staff.11 
 
Between 2010-2014, the Agency for Healthcare Research and Quality (AHRQ) 
reported a 17-percent drop in hospital-acquired conditions (HACs) in the United States.12 
That same report stated the United States saved approximately $19.9 billion due to the 
reduction in HACs.12 AHRQ could not directly credit the HENs with the improvements. 




safety improvements.12 Several articles were published on the HEN programs' improvement 
effects on a smaller, localized scales.13-17 The AHRQ report and additional published articles 
suggested that the HEN program was having a substantial effect. However, not all patient 
safety professionals were convinced about the program’s effectiveness.  
Several patient safety researchers have openly criticized the HEN program with three 
primary critiques.18 The first criticism is that the HENs did not standardize outcome metrics, 
which would have allowed for standardized research across HENs. Second, all of the studies 
conducted on the effectiveness of HENs were lacking a control group. Finally, the data, 
methods, and research were not available for peer review.18 The CMS’s formal evaluation of 
the HEN program addressed the latter two concerns.  
In 2015, Health Services Advisory Group, Inc (HSAG) and Mathematica Policy 
Research formally evaluated the HEN program’s impact on patient harm events. These two 
research organizations used 2011-2014 data from Medicare claims, the Medicare Patient 
Safety Monitoring System, the National Healthcare Safety Network, the National Database 
of Nursing Quality Indicators, and the National Vital Statistics System.19 The researchers 
utilized interrupted time series (ITS) analysis for detecting national trends in the HENs’ 
eleven targeted patient harm areas and difference-in-difference (DID) regression analysis to 
estimate the HEN program’s effectiveness compared to nonparticipants. Of all the HEN-
targeted patient outcomes, the ITS analysis determined that only readmissions experienced a 
positive trend change.19  
The evaluators performed a DID regression analysis on six of the eleven targeted 




three of the six patient outcomes with moderate probability, which was defined as 60% - 80% 
likelihood of cause. The three outcomes with a moderate probability of HEN’s impact were 
venous thromboembolism (2-5%), pressure ulcers (25%), and central-line associated 
bloodstream infections (5-10%).19 Ultimately, the formal evaluation concluded that the HEN 
program’s “impact on outcomes and costs is inconclusive.”19   
While it appears that the formal evaluation supports the HEN critics, the HEN 
supporters countered back stating the lack of empirical evidence does not justify the HENs 
ineffectiveness at driving change.20,21 These supporters argue that setting up robust process 
improvement metrics, running randomized control trials, and executing intricate research 
designs were not the intention of the HEN program. Indeed, the CMS intended the HEN 
program to drive rapid improvements in patient outcomes not serve as an academic model for 
robust research design.20 Another prominent population health researcher stated that while 
quality improvement collaboration is laudable, the model needs additional peer review so 
decisions moving forward can be based on data.22  
Despite the lack of evidence, the CMS continues forward with quality improvement 
collaborations similar to the HENs. The HEN program was followed by the Hospital 
Engagement Network Round 2 program, which launched in September 2015. In Round 2, 
CMS distributed $110 million for one year to 17 quality improvement organizations to 
continue HENs’ original work.23 In 2016, CMS announced a further continuation of the 
program with the Hospital Improvement and Innovation Networks (HIIN). CMS awarded 
$347 million to 16 organizations to improve on the work started by the HEN program. This 




HENs with the Quality Improvement Organizations (QIOs). One complaint of the HEN 
program was that its improvement effort was redundant because CMS had already 
established QIOs to assist with quality improvement efforts. The HIIN program brought 
together these two programs.  
Literature Review  
This literature review section is focused on quality improvement collaborations 
(QICs), specifically the HEN program. Due to the large number of studies on QICs, there 
was a strategic focus only to obtain systematic reviews. For the HEN program search, a more 
granular approach was needed, and all available published articles on HENs were reviewed.   
Quality Improvement Collaboration Review  
The search for QIC systematic reviews was through PubMed, Ovid Medline, and 
Primo. Systematic reviews are summary articles on a particular topic that use rigorous 
selection criteria. There were three known systematic reviews performed on QICs in the past 
decade. These reviews were published in BMJ (2008),25 Milbank Quarterly (2013),26 and 
BMJ Quality & Safety (2018).27  
2008 Systematic Review 
Schouten et al published their 2008 QIC systematic review, Evidence for the impact 
of quality improvement collaboratives: systematic review, in BMJ.25 The review started with 
over 1,000 articles and concluded with nine studies that met the inclusion criteria. From those 
nine studies, two showed positive QIC effects, five showed mixed effects, and two showed 





2013 Systematic Review  
Nadeem et al’s systematic review, Understanding the Components of Quality 
Improvement Collaboratives: A Systematic Literature Review, was published in 2013 in 
Milbank Quarterly. This systematic review’s purpose was to determine what implementation 
methods were consistent across QICs. Then the authors tied those components to 
improvements in provider-level behavioral change and patient-level outcomes. The authors 
only included articles with randomized controlled trials (RCTs) or observational studies that 
were quasi-experimental (i.e., controls included).26   
For provider-level outcomes, there were nine studies with positive effects, eight with 
mixed effects, and two with no effect. For patient-level outcomes, there were three studies 
with positive effects, six with mixed effects, and four with no effects. These authors 
concluded that there was limited evidence for QICs overall effectiveness, especially for 
patient outcomes.26  
2018 Systematic Review 
Wells et al published their 2018 QIC systematic review in BMJ Quality & Safety.27 
The authors used the search methodology from Schouten et al’s 2008 systematic review. The 
systematic review contained 64 studies with 39 in hospital settings. CLABSI was the 
outcome variable for over 20% of the hospital-based studies.27  
There was a statistically significant improvement in at least one of the targeted 
outcomes in 83% of the hospital studies. The authors suggested that while the QICs appear 




those studies.27 Upon reviewing all US-based studies included in this systematic review, 
there were no studies that mentioned the HEN program.  
Hospital Engagement Network Review 
A search was performed in Ovid Medline and Google Scholar for articles with 
“Hospital Engagement Network*” in the full text of articles (excluding citations).  
General Descriptions of HEN Program 
In the HEN program’s first couple of years, several journals published articles about 
the HEN program as a potential way to improve.28-30 These articles merely described the 
program and were not scientific.   
Research Development 
Several HEN organizations enabled research studies on qualitative research, 
observational studies, dissemination efforts, and best practices. HEN programs funded 
research indirectly or directly to provide HEN participants with evidence-based practices. 
One such program was a 10-year follow up study to Dr. Pronovost’s foundational CLABSI 
study.31 Also, HEN program staff also assisted with research studies, such as a review on 
regional variation in CAUTI rates.32 One HEN reached out to its hospital members to have 
them identify research priorities and developed its research agenda accordingly.33 
One of the ways HENs disseminated information was through published studies. 
Studies were published on patient and family engagement,34,35 lean practices,36 estimating 
costs of harm events,37 ADE reductions,38,39 CAUTI improvements,40 maternal care best 





Defining Terms and Metrics 
HENs also served the purpose of performing research to solidify definitions of terms 
and validate quality improvement metrics. One HEN conducted an observational study to 
ensure the correct definition for the diagnosis of CAUTIs.43 Another study validated outcome 
metrics for anticoagulant-associated hemorrhages.44 
Protocols 
Two research protocols were developed to utilize the HEN program to deliver 
interventions. However, no studies or results could be found from either protocol. One 
protocol proposed to evaluate transitional care effectiveness using mixed methods.45 Another 
protocol was a prospective research study with 800 hospitals targeting CAUTI reductions.46 
Outcomes 
Published articles and studies with patient outcomes are listed in this section. These 
outcome studies were categorized into four study settings: 1) single hospital or unit 2) health 
system 3) HEN 4) state or national. As expected, the smaller, more focused studies generated 
more accurate data. As discussed in the background section, no studies used a control group.  
Unit and Hospital 
Three published studies documented HEN participating hospitals having an impact at 
the unit level. Warner et al documented the decrease of pressure ulcers in a hospital’s burn 
unit.17 Rhone et al recorded improvements in catheter insertion techniques in a 1,000+ bed 
hospital’s emergency department.47 Rosenberg et al reported CLABSI reductions in an 




Six published research articles on HEN improvement efforts came from individual 
hospital settings. Tuttle reported a CAUTI reduction in a 600-bed hospital’s critical care 
units.49 Story documented a 500-bed hospital decreasing overall CLABSIs.50 Francis 
recorded a 230-bed hospital’s reduction in Clostridium difficile infections.51 Philips et al 
reported a 145-bed pediatric hospital’s decline in the number of hospital-acquired conditions 
through the HEN program.52 Adams et al documented a rural hospital’s reduced readmission 
rates.14 Kles et al recorded a 350-bed hospital’s decreased surgical site infections.53  
System 
There were four studies at the system level, and these studies did not have the 
methodological rigor as the hospital and unit studies. Fakih et al documented catheter 
placement improvement in 18 emergency departments.54 Frush et al recorded two health 
systems that showed overall safety culture improvements attributed to HEN participation.55 
Eugene A. Woods, president of then Carolinas HealthCare System, stated that HEN 
participation helped them to prevent over 13,000 patient harm events resulting in $80 million 
in cost savings.56 Hendrich and Haydar reported how one health system used the HEN 
program as a step on its official high-reliability journey.57  
Hospital Engagement Network 
At the HEN level, twelve studies, including a mix of qualitative and quantitative 
methods, were published on HEN participation and outcomes achieved. One HEN decreased 
falls by almost 40% across 23 hospitals.58 Two reports stated that rural hospitals, in 
particular, achieved broad performance improvement gains through the HENs.59,60 Other 




and reducing early elective deliveries.63 Two studies evaluated the effect of hospital 
leadership engagement within the HEN program.64,65  
The Children’s Hospitals’ Solutions for Patient Safety (SPS) HEN had the most 
publications of all the HENs. The SPS HEN started with 33 hospitals and has since 
expanded. This HEN published improvement studies on surgical site infection reductions,66 
pressure injury declines,67 and overall improvement gains.68,69  
State/Nation 
Only one study was published evaluating the HEN’s impact on patient outcomes at 
the state level. California developed and sustained better maternal outcomes as a state 
compared to other states. The researchers cited the HEN program as one of the many 
programs that contributed to better outcomes.70 One possible reason for the lack of HEN 
research at the state level is because HENs did not always operate within state boundaries. 
An Iowa-based qualitative study researched how the state attempted to increase cohesiveness 
between all the state-level quality improvement programs.71  
On the national level, over a dozen publsiehd articles declared the HEN program’s 
impact on improving patient outcomes. A report in the American Journal of Health-System 
Pharmacy stated that HENs had decreased adverse drug events by more than 40% across the 
nation.13 In a 2018 Health Affairs article, Donald Berwick, former CMS administrator, cited 
the HENs as a success and an improvement model to be emulated.21 Eleven articles 
mentioned that the HEN program played a role in improving patient care, but these articles 






Pronovost and Jha expressed three criticisms with the HEN program. The first 
criticism is that the HENs did not standardize outcome metrics, which would have allowed 
for standardized research across HENs. Second, all of the studies conducted on the 
effectiveness of HENs were lacking a control group. Finally, the data, methods, and research 
were not available for peer review.18 Mendel et al published an article emphasizing the risk 
change fatigue brought about by a large number of national and regional quality 
improvement initiatives.83 
Confounding Other Research 
Ryan et al’s article on readmissions and federal government interventions described 
how participating in value-based payment programs decreased readmissions. Their study’s 
first limitation was that they could not control for all improvement activities underway at that 
time and explicitly cited the HEN program.84 
Public Health Significance 
The $212 million HEN program has yet to be proven effective at implementing large-
scale change. The CMS’s $9 million formal evaluation stated that the HEN program’s 
“impact on outcomes and costs is inconclusive.”19 No known published studies have 
compared HEN participation to nonparticipation. The federal government continues to spend 
millions of dollars on QICs (e.g., HEN program), yet, there is no empirical evidence that 
hospitals participating in these programs achieve better outcomes than nonparticipants. This 




HEN participants and nonparticipants. The results from this study add to the discussion on 
whether national QIC programs should continue.  
Conceptual Framework 
Based on Donabedian’s model, researchers at the University of Wisconsin-Madison 
developed an improvement model titled the Systems Engineering Initiative for Patient Safety 
(SEIPS).85,86 The SEIPS model separated Donabedian’s structural component into five areas 
within the work system: 1) the person 2) physical environment 3) organization 4) technology 
and tools 5) tasks.86 At the center of the work system was the person who influences, 
changes, and improves the other structural components. These structural modifications 
influenced the care provided and ultimately, patient outcomes.  
Figure 1 displays this study’s conceptual framework which is built on Donabedian’s 
model and the SEIPS model. When hospitals chose to participate in the HEN program, access 
to coaching, best practices, webinars, and other resources became available. A person at the 
hospital consumed this content improved work systems. As previously noted, changes to 
these work systems eventually improved patient outcomes. However, there were additional 
hospital characteristics which are also structural components, but these characteristics were 
not easily changed (bed size, disproportionate share (DSH), and case mix index (CMI). These 
structural attributes also influence care processes which affect patient outcomes (CLABSIs 






Figure 1: Conceptual Framework 
 
Figure 2 displays the HEN program’s implementation overview from policy 
development through improved patient care outcomes. The ACA provisioned funding for 
Patient-Centered Outcomes Research Trust Fund (PCORTF) and Centers for Medicare and 
Medicaid Innovation (CMMI). The PCORTF endowed PCORI and AHRQ to fund research 
organizations to develop evidence-based practices (EBPs). The HENs disseminated EBPs 
through hospital quality improvement (QI) leads. The QI leads subsequently worked with 
multidisciplinary teams to change the hospitals’ work system elements, as discussed 
previously in the conceptual framework. Again, using Donabedian’s approach, the improved 








Table 1:  Conceptual Framework Abbreviations 
 





Agency for Healthcare Research 
and Quality 





Department of Health and Human 
Services 
CMMI 
Center for Medicare and Medicaid 
Innovation 
PCORI 
Patient-Centered Outcome Research 
Institute 
CMI Case Mix Index PCORTF 
Patient-Centered Outcomes Research 
Trust Fund 
CMS 
Centers for Medicare & Medicaid 
Services 
PfP Partnership for Patients 






Aim and Research Questions 
 This study aimed to evaluate whether hospitals participating in a HEN obtained 
superior patient outcomes compared to hospitals that did not participate. This aim was 
achieved by answering two research questions: 1) Did HEN participation lead to decreased 
central line-associated bloodstream infections (CLABSIs)? 2) Did HEN participation lead to 
reductions in 30-day readmission rates for heart failure (HF), acute myocardial infarction 







A retrospective comparative analysis was completed between HEN participants and 
nonparticipants with CLABSI SIRs and 30-day readmission rates (HF, AMI, pneumonia) as 
outcome variables. In the first article, CLABSI SIRs were compared between HEN 
participants and nonparticipants using a fixed effects regression model with annual data from 
2011 through 2014. Similarly, in the second article, 30-day readmission rates were compared 
using a fixed effects regression model with 36-month rolling average data from 2008 through 
2017. In both articles, pre-post trends were analyzed while controlling for hospital 
characteristics. 
Data Collection 
The research database consisted of data from several different public-use data files 
that linked individual hospitals using the Medicare Provider Identification Number. The 
outcomes (for CLABSIs and 30-day readmissions) were collected from the CMS’s Hospital 
Compare archived data repository for a national sample of hospitals identified as general 
acute care with at least 25 inpatient beds.87 Veterans Affairs (VA) hospitals, rehabilitation 
hospitals, dedicated cancer centers, children’s hospitals, mental health facilities, psychiatric 
hospitals, and long-term care facilities were excluded. HEN participation was determined for 
the hospital sample from the “HEN Round 1 hospitals 2015” spreadsheet on the CMS 
Achieved Materials for the Partnership for Patients website.88   
CMS annual impact files were used to determine core-based statistical areas (CBSA), 




available, the correction notice data was used instead of the final rule data. Ownership and 
state variables were obtained from the Hospital Compare’s archived flat file “Hospital 
General Information.” Hospital Compare’s FY12 and FY18 files were used for the first and 
second article, respectively.  
Data Variables 
For article 1, the outcome variable, CLABSI SIR, was a ratio between observed and 
expected CLABSIs. Observed CLABSIs was the numerator, and the denominator was 
expected CLABSIs. Expected CLABSIs are adjusted based on the type of patients that the 
facility treats (e.g., patient care location, bed size of patient care location, and association 
with a medical school).89 The SIR is interpreted similarly to an odds ratio (i.e., a SIR of 
below one represents the hospital had a fewer CLABSIs than expected).  
For article 2, each hospital’s HF, AMI, and pneumonia 30-day readmission rates were 
obtained for each year. The rates represent the moving average of 36-months of data. For 
instance, the fiscal year (FY) 2013 file contained data from July 2009 to June 2012. For the 
final year of the regression analysis, 2012, the readmission data from the FY13 file were 
used. The final year of the three-year moving average period was used for each study year. 
For example, 2010 through 2013 data were used for 2013. This method is commonly used 
when the three-year readmission rate is substituted for annual data.84  
Time-invariant variables (US region, state, CBSAs, teaching designation, and 
ownership) were used as controls in the descriptive analyses and the ordinary least squares 
(OLS) regression models. The CMS impact file used the US Census Bureau’s classification 




Central, West North Central, West South Central, Mountain, and Pacific. The CBSA variable 
was categorized as large urban, other urban, or rural. The ownership variable was categorized 
into government-owned, private nonprofit, and for profit. To address skewness, the 
disproportion share ratio and the number of staffed beds variables were log-transformed. 
Statistical Analysis 
For both articles, the variables were categorized into time-invariant and time-varying 
for the descriptive analysis. The Hausman test was used to determine if a fixed effects or 
random effects regression model was best for the data. Hospital-level data were analyzed 
using several different multivariate fixed effects regression models with CLABSI SIR and 
30-day readmissions as the dependent variables. The fixed effects regression model uses 
panel data to measure variation within a single hospital over time. In other words, this model 
uses each hospital as its own control.90 The fixed effects model includes time-varying, 
independent variables for the number of staffed beds and the disproportionate share ratio. 
Case mix index (CMI) was included in the first article.  
Article 1 
For 2011 data, all hospitals were assigned to the control group since the HEN 
program did not commence until 2012. Then for 2012 through 2014 data, the HEN 
participants were assigned to the intervention group while keeping nonparticipants in the 
control group. This binary change from 0 to 1 for HEN participation enabled the capturing of 
a HEN participation coefficient. 
The data were further analyzed to determine if the starting performance affected the 




SIRs, and a fixed effects regression model was conducted. Since there was only one period of 
pre-intervention data (2011), separating the sample this way controlled for possible bias. 
Hospitals were categorized as high performing (SIR <.25), average (SIR between .25-.69), or 
low performing (SIR >.7) with a third of the sample in each category.  
Finally, the CLABSI SIR variable was zero in 16% of the observations. The CLABSI 
SIR was converted into a binary variable by coding hospitals that experienced a CLABSI as 
one and non-CLABSI hospitals as zero. The binary CLABSI SIR was regressed on time-
varying, independent variables previously listed by using a logit fixed effects model. 
The statistical analyses were completed using Stata v14.2, College Station, Texas. 91 
Article 2 
30-day readmission rates were graphed for ten periods and categorized by HEN 
participation and nonparticipation. An ordinary least squares (OLS) regression model of 
readmissions was estimated for 2008 through 2011 using a binary variable for HEN 
participation as a way to compare HEN participant to nonparticipant performance before the 
program started.  
For the fixed effects model, a binary variable for HEN participation was zero for all 
hospitals through five periods (2008 through 2012). Starting in the sixth period (ending in 
June 2013), HEN participation was labeled as one and nonparticipation as zero. This variable 
allowed for testing the effect of HEN participation on the readmission rate while controlling 
for other time-invariant and time-varying variables. Hospitals with missing outcome data 
were removed, and the fixed effects regression model was executed again to determine if 




To check the validity of the model, two sensitivity analyses were performed. The first 
analysis determined the effect of changing the intervention period in the fixed effects model. 
In the original fixed effects regression, the HEN coefficient was assigned to the start of 
period six (July 2010 through June 2013). The HEN coefficient variable was then assigned to 
the start of periods four, five, and seven. The second analysis was to determine the HEN 
program’s effect during and after the intervention. Periods nine (July 2013 through June 
2016) and ten (July 2014 through June 2017) were omitted, and the fixed effects regression 
model was executed again.  
Human Subjects, Animal Subjects, or Safety Considerations  
The University of Texas School of Public Health’s Institutional Review Board 






JOURNAL ARTICLE #1 
Hospital Engagement Network Participation and Central Line-associated Bloodstream 
Infections 




In 2012, the Partnership for Patients program launched the Hospital Engagement 
Network (HEN) program to reduce eleven types of patient harm events in United States 
hospitals. Evaluation research on the HEN program and other national quality improvement 
collaborations has yet to show definitive results. A formal evaluation of the HEN program 
determined that HEN participations probably outperformed nonparticipating in reducing 
three types of patient harm events, one of which was central-line associated bloodstream 
infections (CLABSIs). The effectiveness analysis was ultimately inconclusive.  
Despite the lack of empirical evidence, the collaboration improvement model 
continued. There was a divide between individuals who believe the model should be 
continued and others who want the model to be further validated as effective. The purpose of 
this study was to provide further evidence of the impact of the HEN program by replicating 
the findings of the formal evaluation regarding HEN-attributable CLABSI improvement in 







We completed a comparative retrospective analysis of the CLABSI standardized 
infection ratio (SIR) from 2011 through 2014 in 1,650 HEN hospitals and 329 control 
hospitals. The CLABSI SIR was regressed on time-varying, independent variables using a 
fixed effects model. The regression model was reestimated separately for hospitals 
categorized as high, medium, and low performers based on 2011 CLASBI SIR data. In 
addition, a logit fixed effects regression model was used to test the relationship by converting 
the CLABSI SIR into a binary dependent variable for CLABSI occurrence.  
Results 
The fixed effects regression model indicated that HEN participation did not reduce 
the CLABSI SIR in participating hospitals (p=.816). When the sample was divided into three 
groups based on baseline performance, the HEN participation coefficient (-.085) was 
significant at the 10% confidence level only for the high performing group (lowest average 
CLASBI SIR in 2011, p=.079). For the other two groups, medium SIR (p=.960) and low SIR 
(p=.848), the HEN participating coefficient was not significantly better than controls. The 
logit model also produced a nonsignificant HEN coefficient (p=.786).  
Conclusions 
This study was unable to show that HEN participation generated CLABSI 
improvement over the study period using a national hospital database and different regression 
models. However, there was a slight improvement in high performing hospitals. Additional 
research is needed to determine if the program may have improved other patient harm events 





In 2001, the Institute of Medicine (IOM) recommended that the United States (US) 
invest in a $1 billion, three- to five-year national patient safety initiative to catalyze a 
national safety movement.1 Nearly a decade later, the Patient Protection and Affordable Care 
Act (ACA) commissioned the Department of Health and Human Services (HHS) to develop 
a national strategy for improving patient outcomes.2 In 2011, HHS launched the Partnership 
for Patients (PfP) initiative with a $1 billion budget to reduce preventable hospital-acquired 
conditions by 40% and readmissions by 20%.3,4   
The PfP initiative allocated $218 million to develop the Hospital Engagement 
Network (HEN) program.3 The HEN program designated 26 organizations as “Hospital 
Engagement Networks” to lead hospitals through quality improvement initiatives. These 
HEN organizations ranged from state hospital associations to for-profit companies. The 
HENs were able to recruit over 3,700 hospitals to join their programs (roughly 72% of all US 
hospitals).5  
The HENs were responsible for improving eleven patient harm events: central line-
associated bloodstream infections (CLABSIs), adverse drug events, catheter-associated 
urinary tract infections, injuries from falls, pressure ulcers, obstetrical adverse events, 
surgical site infections, venous thromboembolism, ventilator-associated pneumonia, 
preventable readmissions, and early elective deliveries.3 
Implementation models varied across the HENs, but all followed the four American 





“1. Facilitate training through a combination of face-to-face meetings and webinars (with replay 
opportunities), monthly coaching calls, and hold quarterly individual calls with each participating 
hospital to provide assistance gauge implementation process, identify barriers and successes and to 
direct development of additional supporting resources  
2. Require hospitals to report process measures to assure implementation of key process changes, and 
benchmark progress  
3. Provide technical assistance when triggers are hit (outliers based on data)  
4. Leadership Engagement and support of unit-level activities and needs to include rounding, 
understanding of data and regular reporting to Board and hospital staff.” 6 
Initial reports appeared that the HENs achieved significant patient harm 
improvements. Between 2010 through 2014, AHRQ reported a 17 percent drop in hospital-
acquired conditions (HACs) in the US.7 That same report stated the US saved approximately 
$19.9 billion due to the reduction in HACs.7 AHRQ could not directly credit the HENs with 
the improvements. However, the report mentioned the HENs catalytic efforts on reducing 
patient harm.7 Numerous studies were published suggesting HEN participants had decreased 
patient harm events, but none of these studies used control groups.8-12 While the HEN 
outcomes appeared promising, not all patient safety professionals were convinced.  
Several patient safety researchers have openly criticized the HEN program with three 
primary critiques.13 The first is that the HENs did not standardize outcomes metrics which 
would have allowed for standardized research across HENs. Second, all research studies 
conducted on the effectiveness of HENs before 2014 were lacking a control group. Finally, 
the data, methods, and research were not available for peer review.13 CMS commissioned a 
formal evaluation of the HEN program to address the latter two concerns.  
In 2015, Health Services Advisory Group, Inc (HSAG) and Mathematica Policy 




research organizations used 2011 through 2014 data from Medicare claims, the Medicare 
Patient Safety Monitoring System, the National Healthcare Safety Network, the National 
Database of Nursing Quality Indicators, and the National Vital Statistics System.14 The 
researchers utilized interrupted time series (ITS) analysis for detecting national trends in the 
HENs’ eleven targeted patient harm areas difference-in-difference (DID) regression analysis 
to estimate the HEN program’s effectiveness compared to nonparticipants. The ITS analysis 
determined that none of the patient harm areas experienced a national positive trend 
change.14 The DID analysis determined that the HEN hospitals performed better in three of 
the six patient outcomes with moderate probability, defined as 60% to 80% likelihood of 
causality. The three outcomes with a moderate probability of the HEN’s impact were venous 
thromboembolism (2-5%), pressure ulcers (25%), and CLABSIs (5-10%).14  
Ultimately, the formal evaluation concluded that the HEN program’s “impact on 
outcomes and costs is inconclusive.”14 While it appeared that the formal evaluation did not 
validate the HEN program’s effectiveness, HEN supporters countered by stating the lack of 
empirical evidence did not justify concluding that the HEN program was ineffective in 
driving change.15,16   
One leader in population health stated that while quality improvement collaboration is 
laudable from a theoretical perspective, the industry needs empirical evidence for decisions.17 
Despite the lack of evidence, CMS continued with quality improvement collaborations 
similar to the HENs.    
The purpose of this study was to contribute to the HEN discussion by evaluating the 




known study to examine the HEN program’s outcomes with a nonparticipating control group. 
The outcome variable was the CLABSI standardized infection ratio (SIR) as documented in 
Hospital Compare. The focus on CLABSIs was because the formal evaluation found a 
moderate probability of likelihood of HEN hospitals outperforming nonparticipants on this 
particular measure, and CLABSI data were publicly available.  
Methods 
Study Design 
We compared CLABSI SIRs between HEN participants and nonparticipants using a 
fixed effects regression model with annual data for 2011 through 2014.  Pre-post trends were 
analyzed while controlling for hospital characteristics. The University of Texas School of 
Public Health’s Institutional Review Board determined this study was exempt from human 
subjects’ protection. 
Data Collection 
The research database consisted of data from several different public-use data files 
that linked individual hospitals using the Medicare Provider Identification Number. We 
collected CLABSI outcome from the CMS’s Hospital Compare archived data repository for a 
national sample of hospitals identified as general acute care with at least 25 inpatient beds.18 
Veterans Affairs (VA) hospitals, rehabilitation hospitals, dedicated cancer centers, children’s 
hospitals, mental health facilities, psychiatric hospitals, and long-term care facilities were 
excluded.  HEN participation was determined for the hospital sample from the “HEN Round 
1 hospitals 2015” spreadsheet on the CMS Achieved Materials for the PfP website.19 CMS 




based statistical areas (CBSA), US regional location, teaching hospital status, and 
disproportionate share (DSH) ratio. When available, the correction notice data was used 
instead of the final rule data. Ownership and state variables were obtained from the Hospital 
Compare’s FY12 archived flat file “Hospital General Information.”  
Data Variables 
The outcome variable, CLABSI SIR, is a ratio between observed and expected 
CLABSIs. The numerator was observed CLABSIs with the denominator as expected 
CLABSIs. Expected CLABSIs are adjusted based on the type of patients that the facility 
treats (e.g., patient care location, bed size of patient care location, and association with a 
medical school).20 The SIR is interpreted similarly to an odds ratio (i.e., a SIR of below one 
represented the hospital had a fewer CLABSIs than expected).  
Time-invariant variables (US region, state, CBSAs, teaching designation, and 
ownership) were used as controls in the descriptive analyses and the ordinary least squares 
(OLS) regression models. The CMS impact file used the US Census’s classification for 
regions: New England, Mid Atlantic, South Atlantic, East North Central, East South Central, 
West North Central, West South Central, Mountain, and Pacific. The CBSA variable was 
categorized as large urban, other urban, or rural. We categorized the ownership variable into 
government-owned, private nonprofit, and for profit. We log-transformed the disproportion 
share ratio and the number of staffed beds variables to address skewness.  
Statistical Analysis 
The variables were categorized into time-invariant and time-varying for the 




effects regression model was best for the data. We analyzed hospital-level data using several 
different multivariate fixed effects regression models with CLABSI SIR as the dependent 
variable. The fixed effects regression model uses panel data to measure variation within a 
single hospital over time. In other words, this model uses each hospital as its own control.21 
The fixed effects model includes time-varying, independent variables for the number of 
staffed beds, DSH ratio, and case mix index (CMI). 
To capture HEN participation, we assigned the binary variable of 0 for 
nonparticipation and 1 for participation. This change from 0 to 1 in HEN participation 
enabled us to capture a coefficient for HEN participation. For 2011 data, we assigned all 
hospitals with a  variable of 0 since the HEN program did not commence until 2012. Then for 
2012 through 2014 data, we assigned HEN participants with a 1 for the HEN participation 
variable.  
We further analyzed the data to determine if the starting performance affected the 
HENs’ impact on CLABSIs. We divided the sample into thirds based on 2011 CLABSI SIRs 
and conducted a fixed effects regression model. Since there was only one period of pre-
intervention data (2011), separating the sample this way controlled for possible bias. We 
categorized hospitals as high performing (SIR <.25), average (SIR between .25-.69), or low 
performing (SIR >.7) with a third of the sample in each category.  
Finally, the CLABSI SIR variable was zero in 16% of our observations. We 
converted the CLABSI SIR into a binary variable by coding hospitals that experienced a 




SIR on time-varying, independent variables previously listed by using a logit fixed effects 
model. The statistical analyses were completed using Stata v14.2, College Station, TX. 22  
Results 
Descriptive Statistics 
Our sample contained 1650 HEN participating hospitals from each of the 26 HENs 
and 329 nonparticipating hospitals. Our sample’s HEN participation rate of 83% was well 
above the national average of 72%. We addressed this disparity as a limitation in the 
discussion section.  
Table 1 displays the time-invariant characteristics of the hospitals.  HEN participation 
was disproportionately smaller in the West South Central Region (Oklahoma, Arkansas, 
Texas, Louisiana) and South Atlantic Region (Maryland, Delaware, West Virginia, Virginia, 
North Carolina, South Carolina, Georgia, Florida, District of Columbia). Another difference 
between the two groups was the high proportion of for-profit hospitals in the nonparticipation 
group. Finally, while the majority of HEN participants were teaching hospitals, this was only 





Table 1:  Descriptive Statistics for Time-invariant Variables 
 
Descriptive Statistics for Time-invariant Variables 
 HEN Participants Nonparticipants 
Variables n (% of sample) n (% of sample) 
Region 
   New England 
   Mid Atlantic 
   South Atlantic 
   East North Central 
   East South Central 
   West North Central 
   West South Central 
   Mountain  






















   Rural 
   Small Urban 










   Yes 








   Government 
   Private Nonprofit 










Table 2 displays the time-varying hospital characteristics from the 2011 data that 
were used in the fixed effects regression model and the CLABSI SIR by year. On average, 
nonparticipants had a lower case mix index, fewer beds, and higher disproportionate share 
ratio than the HEN participants.  The CLABSI SIR was lower for HEN participants than 
nonparticipants in each of the four years. Moreover, the average CLABSI SIRs decreased 





Table 2:  Descriptive Statistics for Time-varying Variables in 2011 
 
Time-varying Hospital Characteristics in 2011 
 HEN Participants Nonparticipants  
Variables Mean (sd) Mean (sd) P-value (t-test) 
Fixed Effect Variables 
   Case Mix Index (2011) 
   Beds (2011) 













CLABSI SIRs by Year 
   2011 
   2012 
   2013 


















The Hausman test (p<.01) confirmed that only the fixed effects regression model 
should be estimated for both the fixed effects regression and logit regression with fixed 
effects.  
Table 3 displays the results of our first fixed effects regression model. The HEN 
participation coefficient was .007 (p=.816). The only independent variable with a statistically 
coefficient was 2014. On average, all hospitals had lower CLABSI SIRs in 2014 compared to 





Table 3:  CLABSI SIR Fixed-effects Regression 
 
CLABSI SIR Fixed-effects Regression  
Variables Coefficient P-value 95% C.I.  
In Hen 
   No (reference)  



















-.247   .094 
-.093   .086 
-.319   .120 
Year    
   2011 (reference)   
   2012 
   2013 










-.058   .064 
-.108   .015 
-.152   -.027 
  * Statistically significant at p < .05  
 
Table 4 summarizes the results of the fixed effect regression model when the sample 
was divided into thirds based on 2011 CLABSI SIRs. Based on the baseline year of 2011, 
hospitals were categorized as high performing (SIR score <.25), average (.25-.69), or low 
performing (>.7). The only group with a significant HEN participation coefficient was the 
high performing group  (-.085, p=.079). Both high performing and low performing groups 
experienced a regression to the mean by having three statistically significant years (2012, 





Table 4:  Fixed Effects Regression with SIR Score Grouped by 2011 Baseline 
 
Fixed Effects Regression with SIR Score Grouped by 2011 Baseline  
 High Performing Average Low Performing 
Variables Coefficient P-value Coefficient P-value Coefficient P-value 
In Hen 
   No (reference) 








































Year       
   2011(reference)   













   2013 .434* .001 .057 .192 -.533* .001 
   2014 .382* .001 .035 .425 -.591* .001 
* Statistically significant at p < .05 
 
Finally, we converted the CLABSI SIR into a binary variable by coding hospitals that 
experienced one or more CLABSI cases during the year as one and hospitals with no 
CLABSI cases as zero. We then regressed the binary CLABSI SIR on time-varying, 
independent variables by using a logit fixed effects regression model. The results of this 
regression are summarized in Table 5. As indicated in the table, there was no significant 
relationship between HEN participation and CLABSI events (p=.786).  
Table 5:  Logit Fixed Effects Regression  
 
CLABSI SIR Logit Fixed Effects Regression  
Variables Coefficient P-value 95% C.I.  
In Hen 
   No (reference)    



















-1.369   .648 
-.524   .650 
-.940   1.749 
Year    
   2011 (reference)   
   2012 
   2013 










-.058   .064 
-.108   .015 
-.152   -.027 





Our study added further empirical evidence to the ongoing debate on whether large-
scale quality improvement collaborations, such as the HEN program, have been effective. 
We were unable to corroborate the formal HEN evaluation that HEN hospitals decreased 
CLABSI rates with HEN participation. The one exception is that high performing hospitals 
experienced a moderate improvement from HEN participation (-.085, p=.079). Both HEN 
hospitals and nonparticipants decreased their CLABSI SIR over four years, 17% and 14% 
respectively.  
It is unknown what precisely was driving the CLABSI improvements at this time. 
Additionally, it is unknown how nonparticipants were able to achieve similar improvement 
results to the HEN participants.  
One possibility is that the nonparticipating hospitals gained quality improvement 
knowledge through “spillover.”14 For instance, the nonparticipating hospitals may have 
experienced some benefits (e.g., receiving toolkits, attending conferences, viewing webinars) 
without participating in time-intensive tasks such as regular reporting of process measures 
and attending mandatory meetings.  
Increasing healthcare market pressures such as value-based purchasing, increased 
consumer demands, mandated reporting requirements, and reimbursement withheld for poor 
quality may have contributed to CLABSI declines.  
The final interpretation of the insufficient findings was that the HENs were not 
effective in delivering quality improvement interventions. This study is consistent with the 




sustained improvements. Additionally, the HENs, as QICs, might have experienced 
diminishing returns on their efforts. On the national level, new quality improvement models 
may be needed to scale future interventions.  
Limitations 
This study has several limitations for consideration. The first limitation is that critical 
access hospitals (CAHs) were omitted because CMS did not report CAH CLABSI data in 
2011. Omitting these hospitals likely created sampling bias. For instance, in our study, we 
had a HEN participation rate of 83%. However, the national average HEN participation rate 
was approximately 72%. Due to the CAH omissions, our study was missing the proportionate 
amount of controls.  
The inability to quantify motivation is a common limitation of quality improvement 
observational studies. As such, this study does not have a variable to capture a hospital’s 
willingness to improve. Hospitals with a high motivation to improve might have been more 
likely to join a HEN. Therefore, it was the desire to improve that led to better outcomes, not 
necessarily HEN program participation. 23  
The CLABSI SIR data were only available from 2011 through 2014, which resulted 
in a short time-series panel. CLABSI SIR data before 2011 was not available in the Hospital 
Compare data archive. In 2015, the National Healthcare Safety Network (NHSN) updated 
how the CLABSI SIR was calculated.24 Therefore, we were unable to directly compare 2015 
CLABSI SIR data with the other years in our panel.  
Omitted variable bias was a concern with this study. Several quality improvement 




and bundled payments.25 Our research did not control for other improvement efforts in which 
hospitals could have participated.  
Additional Research  
Our study reviewed one of the 11 patient harm outcomes targeted by the HEN 
program. Further research is needed on other outcomes to determine if the results are similar.  
Additional research is needed to understand why there was such a reduction in CLABSIs 
between 2011 and 2014. Several policy changes, improvement efforts, and technology 
enhancements were underway during this time. Therefore, it will be challenging to find the 
primary source of improvement. Recent research states it was most likely a combination of 
events working in tandem.25  
In the future, quality improvement research should also consider conducting 
prospective cost-effectiveness analyses of QICs interventions. The cost-effectiveness 
perspective is essential if QICs were effective but started to experience diminishing returns. 
Understanding the actual cost of these national QIC interventions is necessary to determine 
the cost per outcome gained is justified.    
Finally, the HEN program’s new iterations should be researched and evaluated. 
Launched in 2015, HEN 2.0 followed in the footsteps of the original HEN program. In 
version 2.0, CMS distributed $110 million for one year to 17 quality improvement 
organizations to continue the HENs’ original work.26 In 2016, CMS announced a further 
continuation of the program with the Hospital Improvement and Innovation Networks 




work started by the HEN program. 27 However, there have been no studies reviewing the 
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JOURNAL ARTICLE #2 
Hospital Engagement Network Participation and 30-day Readmission Rates 




This study evaluated the impact of Hospital Engagement Network (HEN) 
participation on 30-day readmission rates for heart failure (HF), acute myocardial infarction 
(AMI), and pneumonia.  
Method 
We completed a comparative retrospective analysis of HEN hospitals and control 
hospitals utilizing Hospital Compare’s 30-day readmission data from 2005-2017. We 
regressed changes in 30-day readmission rates for HF, AMI, and pneumonia on time-varying, 
independent variables using a fixed effects regression model and conducted multiple 
sensitivity analyses.  
Results 
There were a total of 76,900 hospital years of data with 30-day readmission rates for 
HF (28,280), AMI (20,936), pneumonia (27,684). The pre-post fixed effect regression 
coefficients for HEN participation were varied for HF (.018, p=.639), AMI (-.073, p=.032), 
and pneumonia (.097, p=.003). When using full panel data, the fixed effect regression 
coefficients were similar to the original sample with 30-day readmission rates for HF(-.032, 




determined that HEN participants achieved superior AMI readmission improvements over 
nonparticipants before the HEN program commenced.  
Conclusions 
In this study, we determined that there is little evidence that HEN participation in 
reducing 30-day readmissions. Policymakers should consider the lack of improvement 





In 2001, the Institute of Medicine (IOM) recommended that the United States should 
invest in a $1 billion, three-to-five-year national patient safety initiative to catalyze a national 
safety movement.1 In 2010, the Patient Protection and Affordable Care Act (ACA) 
commissioned the Department of Health and Human Services (HHS) to develop a national 
strategy for improving patient outcomes.2 In 2011, HHS launched the Partnership for Patients 
(PfP) initiative with a $1 billion budget to reduce preventable hospital-acquired conditions by 
40% and readmissions by 20%.3,4 A 20% reduction in readmissions would have resulted in a 
decline of 1.6 million readmissions.3  
The PfP initiative allocated $218 million to develop the Hospital Engagement 
Network (HEN) program.3 The HEN program designated 26 organizations as “Hospital 
Engagement Networks” to lead hospitals through quality improvement initiatives. These 
HEN organizations ranged from state hospital associations to for-profit companies. The 
HENs were able to recruit over 3,700 hospitals to join their programs.5  
The HEN program was a result of the federal government’s increasing reliance on 
Quality Improvement Collaborations (QICs) to implement large-scale change. QICs were 
defined as multiorganizational systems striving together to improve patient outcomes.6 The 
Institute for Healthcare Improvement’s (IHI) Breakthrough Series formalized and codified 
the modern QIC structure.7 Effectiveness studies on QICs have been mixed.6-8  
A 2014 QIC systematic review identified standard components of collaboratives. The 
HEN organizations utilized these components, which included expert panels synthesizing 




quality improvement teams, conference calls, and email support.8 The American Hospital 
Association recommended four improvement tactics: 1) clear, regular communications 
between HEN organization and hospitals 2) hospitals should report process measures 3) HEN 
should intervene when process measures are out of alignment with goal 4) hospitals’ 
leadership engagement.9 
Several patient safety researchers have openly criticized the design of the HEN 
program and studies of its impact. The criticisms focus primarily on three areas.10 First, the 
HENs did not standardize outcomes metrics which would have allowed for standardized 
research across HENs. Second, all of the studies conducted on the effectiveness of HENs 
were lacking a control group. Finally, the data, methods, and research were not available for 
peer review.10  
The Centers for Medicare & Medicaid’s (CMS) sponsored evaluation, conducted by 
the Health Services Advisory Group, Inc. and Mathematica Policy Research in 2015, 
addressed the latter two concerns. This study used 2011 through 2014 Medicare claims data, 
the Medicare Patient Safety Monitoring System data, the National Healthcare Safety 
Network data, the National Database of Nursing Quality Indicators, and the National Vital 
Statistics System data.11 The researchers conducted an interrupted time series (ITS) analysis 
to detect national trends in the HENs’ eleven targeted patient harm areas and difference-in-
difference (DID) regression analysis to estimate the HEN program’s impact on participants 
compared to nonparticipants. Of the eleven HEN-targeted patient harm events, the ITS 
analysis determined only one area, readmission rates, were significantly impacted.11 The 




2014.11 This decline fell short of the 20% goal established by CMS. In the DID regression, 
HEN participants and nonparticipants performed the same for 30-day all-cause readmissions. 
Ultimately, the formal evaluation concluded that the HEN program’s “impact on outcomes 
and costs is inconclusive.”11   
While the formal evaluation supported HEN critics, HEN supporters countered that 
the lack of empirical evidence did not justify a conclusion of ineffectiveness.12,13 They 
argued that setting up robust collaborative processes and metrics to drive improvements in 
patient outcomes were significant accomplishments with the potential for future 
improvement.12 One leader in population health stated that while quality improvement 
collaboration is laudable, the industry needs additional peer review for decisions based on 
data.14 Currently, CMS continues to support quality improvement collaborations similar to 
the HENs.    
The purpose of this study was to contribute to the HEN evidence base in several 
ways.  First, by comparing the HEN program’s outcomes with a nonparticipating control 
group. Second, by using three distinct readmissions outcome variables (HF, AMI, and 
pneumonia) instead of 30-day all-cause readmissions. Finally, by using readmission data 






We compared changes in readmission rates between HEN participants and 
nonparticipants using a fixed effects regression model with 36-month moving average data 
for 2008 through 2017. Pre-post trends were analyzed while controlling for hospital 
characteristics. The University of Texas School of Public Health’s Institutional Review 
Board determined this study was exempt from human subjects’ protection.  
Data Collection 
The research database consisted of public-use data files linked to individual hospitals 
by using the Medicare Provider Identification Number. We collected readmission data from 
the CMS’s Hospital Compare archived data repository for a national sample of hospitals 
identified as general acute care with at least 25 inpatient beds.15 Veterans Affairs (VA) 
hospitals, rehabilitation hospitals, dedicated cancer centers, exclusive children’s hospitals, 
mental health facilities, psychiatric hospitals, and long-term care facilities were excluded. 
HEN participation was determined for the hospital sample from the “HEN Round 1 hospitals 
2015” spreadsheet on the CMS Achieved Materials for the Partnership for Patients website.16  
CMS annual impact files for fiscal year (FY) 2009 through 2018 were used to determine 
core-based statistical areas (CBSA), US regional locations, and the disproportionate share 
(DSH) ratio. When available, the correction notice data were used instead of the final rule 
data. Ownership and state variables were obtained from the Hospital Compare’s FY18 
archived flat file “Hospital General Information.” Teaching hospital designation was based 




Variables and Measures 
Each hospital’s HF, AMI, and pneumonia 30-day readmission rates were obtained for 
each year. The rates represent the moving average of 36-months of data. For instance, the 
FY2013 file contains data from July 2009 through June 2012.  For the final year of the 
regression analysis, 2012, the readmission data from the FY13 file were used. The final year 
of the three-year moving average period was used for each study year. For example, 2010 
through 2013 data were used for 2013. This method was used in other studies when the three-
year readmission rate was substituted for annual data.17  
Time-invariant variables (US region, state, CBSAs, teaching designation, and 
ownership) were used as controls in the descriptive analyses and the ordinary least squares 
(OLS) regression model. The CMS impact file used the US Census Bureau’s classification 
for regions: New England, Mid Atlantic, South Atlantic, East North Central, East South 
Central, West North Central, West South Central, Mountain, and Pacific. The CBSA variable 
was categorized as large urban, other urban, or rural. We categorized the ownership variable 
into government-owned, private nonprofit, and for profit. We log-transformed the 
disproportionate share ratio and the number of staffed beds variables to address skewness.  
Analysis 
The variables were time-invariant and time-varying. The 2012 data from the FY 2013 
impact file was analyzed to develop graphs of the average 30-day readmission rates 
throughout the ten periods categorized by HEN participation and nonparticipation. An 




through 2011 using a binary variable to compare HEN participant-nonparticipant rates before 
the program started.  
The Hausman test was used to determine if a fixed effects or random effects 
regression model was best for the data. The fixed effects regression model used panel data to 
measure variation within a single hospital over time, using each hospital as its own control.18 
The model included categorical independent variables for the number of staffed beds, 
operating margin, DSH ratio, and case mix index. A binary variable for HEN participation 
was zero for all hospitals through five periods (2008 through 2012) and one for HEN 
participants starting in the sixth period, July 2012. This variable allowed us to test the effect 
of HEN participation on the readmission rate while controlling for other time-invariant and 
time-varying variables.  
We removed hospitals that were missing outcome data and ran the fixed effects 
regression model again to determine if strongly balanced panels achieved the same results.  
We performed two sensitivity analyses. The first analysis determined the effect of changing 
the original intervention period in the fixed effects model from period six to periods four, 
five, and seven. The second analysis was to determine if there were differences in the HEN 
program’s effect during and after the intervention. We eliminated periods that contained 18 
months and 30 months of data after the HEN program completion in December 2014. The 








The sample contained 3,275 HEN participating hospitals from all 26 HENs and 1,164 
nonparticipating hospitals from throughout the United States who reported readmission 
outcome data. The sample’s HEN participation rate of 73% was in line with the national 
average of 72%. Hospitals with full panels of all three segments of outcome data were 1,083 
HEN participants and 192 nonparticipants.  
Table 1 displays the descriptive statistics for 2012, the year with most details on the 
hospitals. HEN participation was disproportionately smaller in the West South Central 
Region (Oklahoma, Arkansas, Texas, and Louisiana). The urban/rural geographic 
distribution was similar for the two groups. HEN participants had twice the percentage of 
teaching hospitals as nonparticipants. Finally, the nonparticipating cohort had twice the 





Table 1:  Descriptive Statistics for Time-invariant Variables 
 
Descriptive Statistics for Time-invariant Variables 
 HEN Participants Nonparticipants 
Variables % of sample % of sample 
Region 
   New England 
   Mid Atlantic 
   South Atlantic 
   East North Central 
   East South Central 
   West North Central 
   West South Central 
   Mountain  






















   Rural 
   Small Urban 










   Yes 








   Government 
   Private Nonprofit 










Table 2 displays the time-varying variables for our fixed effects regression model. On 
average, nonparticipants had a lower case mix index, fewer beds, and higher disproportionate 
share ratio than the HEN participants. Figure 1 displays the 30-day readmission rate for AMI, 
HF, and pneumonia by HEN participation. 
Table 2:  Descriptive Statistics for Time-varying Variables 
 
Descriptive Statics for Time-varying Variables 
 HEN Participants Nonparticipants  
Variables Mean (sd) Mean (sd) P-value (t-test) 
Fixed Effect Variables 
   Case Mix Index  
   Beds 


















Figure 1:  30-day Readmission Rates between HEN Participants and Nonparticipants 
 
 
OLS Regression Model 
Table 3 displays the OLS regression results for HF, AMI, and pneumonia 30-day  
readmission rates from the four periods ending in 2008 through 2011. The HEN coefficients 
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HEN hospitals were obtaining superior results before the HEN program began in 2012. The 
coefficients for bed size, DSH, geographic location, were statistically significant (p<.001) 
across all three readmission outcomes.  
When the state was used as an independent variable compared to the region, it yielded 
a higher adjusted R-squared, and many states were statistically significantly related to the 
outcomes. However, state information was not relevant to our study. Therefore, we did not 
list this information in Table 2.  
Table 3:  OLS Regression for Readmissions in 2008-2011 
 
 OLS Regression for Readmissions in 2008-2011 
 HF AMI Pneumonia 
Variables Coefficient P-value Coefficient P-value Coefficient P-value 
In Hen 
   No (reference)  


































   No (reference) 
   Yes 
Hospital Type (omitted) 
Geography 
   Rural (reference) 
   Small Urban 
   Large Urban 

















































Year       
   2005-2008 (reference)   
   2006-2009 
   2007-2010 

































We analyzed hospital-level data using a multivariate fixed effects regression model of 
the readmission outcomes (HF, AMI, and pneumonia).  Both multivariate fixed effects and 
random effects regressions were estimated using Stata. The Hausman test (p<.01) confirmed 
that the fixed effects regression model was the best fit for the data.    
Table 4 below shows the fixed effects result with all observations included in the 
sample. There were a total of 76,900 hospital years in the data for HF (28,280), AMI 
(20,936), and pneumonia (27,684). The HEN coefficients for AMI (-.073, p=.032) and PN 
(.097, p=.003) were both statistically significant but in opposite directions. On average, HEN 
participation decreased AMI readmission rates by .073 percentage points. However, HEN 
participation was associated with a .097 percentage point increase in pneumonia readmission 
rates. The HF readmission rate was not affected by HEN participation (.018, p=.639). The 






Table 4:  Fixed Effects Model of Readmissions in 2008-2017 
 
 Fixed Effects Model of Readmissions in 2008-2017 
 HF AMI Pneumonia 
Variables Coefficient P-value Coefficient P-value Coefficient P-value 
In Hen 
   No (reference)  

































Year       
   2005-2008 (reference)   
   2006-2009 
   2007-2010 

























   2009-2012 -1.46* <.001 -1.60* <.001 -.582* <.001 
   2010-2013 -1.81* <.001 -2.01* <.001 -.933* <.001 
   2011-2014 -2.50* <.001 -2.85* <.001 -1.33* <.001 
   2012-2015 -2.55* <.001 -2.95* <.001 -1.13* <.001 
   2013-2016 -2.87* <.001 -3.54* <.001 -1.30* <.001 
   2014-2017 -2.88* <.001 -3.86* <.001 -1.54* <.001 
  * Statistically significant at p < .05     
 
Table 5 displays the fixed effects results for hospitals with full panels (i.e., hospitals 
with readmission rates reported for all ten study years). There were a total of 58,530 hospital 
years in the data for HF (26,650), AMI (12,810), and pneumonia (19,070).  
The HEN coefficients for the full sample mirrored those of the original sample. The 
HEN participation coefficients for AMI (-.148, p=.001) and pneumonia (.103, p=.014) were 
again significant in opposite directions. For HF, the HEN participation coefficient was not 






Table 5:  Fixed Effects Regression Results for Readmissions in 2008-2017 for Full Panels 
 
Fixed Effects Regression Results for Readmissions in 2008-2017 for Full Panels 
 HF AMI Pneumonia 
Variables Coefficient P-value Coefficient P-value Coefficient P-value 
In Hen 
   No (reference)  

































Year       
   2005-2008 (reference)   
   2006-2009 
   2007-2010 

























   2009-2012 -1.45* <.001 -1.63* <.001 -.598* <.001 
   2010-2013 -1.76* <.001 -1.98* <.001 -.949* <.001 
   2011-2014 -2.45* <.001 -2.83* <.001 -1.37* <.001 
   2012-2015 -2.51* <.001 -2.91* <.001 -1.09* <.001 
   2013-2016 -2.81* <.001 -3.51* <.001 -1.27* <.001 
   2014-2017 -2.82* <.001 -3.81* <.001 -1.51* <.001 
  * Statistically significant at p < .05     
 
Sensitivity Analysis 
Table 6 displays the results of the first sensitivity analysis performed with the fixed 
effects model with the HEN coefficient starting in periods four (July 2008 through June 
2011), five (July 2009 through June 2012), and seven (July 2011 through June 2014).  
Table 6:  Sensitivity Analysis for the Start of the HEN Program 
 
Sensitivity Analysis for the Start of the HEN Program 
 HF AMI Pneumonia 
HEN Coefficient Coefficient P-value Coefficient P-value Coefficient P-value 
Period 4 (July 08-June 11) 
Period 5 (July 09-June 12) 
Period 6 (July 10-June 13) 






























 The HF HEN coefficient was not significant for each of the four periods. Therefore, 
no matter the timing of the HEN intervention in the statistical analysis, there was no effect of 
HEN participation on the HF readmission rate.  
 The HEN coefficient for AMI was significant for each of the fixed effects 
regressions, including period four, which was before the HEN program commenced. 
Therefore, HEN participants started experiencing improved AMI readmission rates before 
the program began.  
 Finally, HEN participants experienced worse pneumonia readmission rates during the 
program. The HEN coefficient was not statistically significant until measured starting in the 
sixth period.  
A second sensitivity analysis was performed to eliminate the last two periods of this 
study. Periods nine (July 2013 through July 2016) and ten (July 2014 through June 2017) 
contained observations after the HEN program ended in December 2014. Table 7 displays the 
results of dropping the last period and the last two periods from our analyses. When these 
periods were dropped, there was not a significant change in the HEN participation 
coefficients.  
Table 7:  Sensitivity Analysis for when the HEN Program Ended 
 
Sensitivity Analysis for when the HEN Program Ended 
 HF AMI Pneumonia 
HEN Coefficient Coefficient P-value Coefficient P-value Coefficient P-value 
All Ten Periods (original model) 
Drop Period 10 (June 14-July 17) 


























Our study added further empirical evidence to the ongoing debate on whether large-
scale quality improvement collaborations, such as the HEN program, have been effective. 
Our study expanded on previous HEN research on readmissions by breaking out 30-day 
readmissions into HF, AMI, and pneumonia. Also, our study sample contained years beyond 
on the HEN program’s conclusion, allowing us to review sustainability after the HEN 
program concluded.  
In our sample, we were unable to show that HEN participation lead to declined 
readmission rates. Only one HEN coefficient, AMI showed statistically significant 
improvements for HEN participation (-.073, p=.032). However, a sensitivity analysis 
determined that HEN participants started reducing readmission rates compared to the 
nonparticipants before the HEN program commencing. The HEN participation coefficient for 
HF was not significant (.018, p=.693). The pneumonia HEN coefficient determined that HEN 
participation was associated with a statistically significant decline (.097, p=.007). The 
statistically significant results from AMI and pneumonia were still less than one-tenth of a 
percentage point resulting in a small effect size.  
There are a few reasons as to why the HEN participants did not outperform 
nonparticipants. Since HEN participating hospitals achieved better readmission rates before 
the HEN program, it might have been difficult to accelerate improvements over the 
nonparticipants further. Another possibility is that the nonparticipating hospitals gained 




hospitals may have experienced some benefits (e.g., receiving toolkits, attending 
conferences, viewing webinars) without participating in time-intensive tasks such as regular 
reporting of process measures and attending mandatory meetings.   
Limitations 
Our study had a few limitations. The first limitation was that we did not control for 
mortality rates, which were possibly correlated with readmission rates.20  
Next, we did not know which hospitals dropped out of the HEN program. Some 
research shows that up to 30% of QIC participants drop out.21 Similarly, this study did not 
have a variable to capture a hospital’s willingness to improve. The inability to quantify 
motivation is a common limitation of quality improvement observational studies. Hospitals 
with a high motivation to improve might have been more likely to join a HEN. Therefore, a 
hospital's desire to improve leads to better outcomes not necessarily the HEN program.22  
Omitted variable bias was also a concern with this study. Several quality 
improvement efforts were ongoing at this time. These efforts included Meaningful Use, 
accountable care organizations, and bundled payments.17 Our study does not control for when 
hospitals joined these other programs or even the next round of HEN programs.  
Additional Research  
This study was the first known study that evaluated HEN participation with 
nonparticipation on reducing hospital readmissions. Since this study was modeled after Ryan 
et al’s readmission study,17 further research should combine their data with this study’s HEN 
data. Combining the data sets would determine if HEN participation is significant while 




Also, additional research could determine the effect of programs such as the Hospital 
to Home initiative or the American Heart Association’s Get with the Guidelines impact in 
reducing cardiovascular readmission rates.23,24 Since HEN participants achieved better 
outcomes for AMI readmissions before the HEN program, one possibility is that HEN  
participants previously participated in one of these other programs. 
Future QICs studies should evaluate using technology as a means to drive 
effectiveness. The QIC systematic review on methods did not mention the use of 
implementation software as a popular implementation tool. Using updated technologies may 
lead to superior outcomes.   
Additional research should focus on penalties and participation in QICs. In the past 
decade, large QICs were preceded by policy developed penalties. For instance, Meaningful 
Use threated penalties if providers did not adopt electronic health record (EHRs). However, 
simultaneously, the federal government created Regional Extension Centers (RECs) to aid 
EHR adoption. In 2012, the Hospital Readmissions Reduction Program began penalizing 
hospitals for readmissions. While at the same time, the HENs assisted hospitals with 
decreasing readmission rates. For example in one qualitative study, several interviewees cited 
policy changes as a reason for joining a HEN.25 There were several studies published on 
policy changes improving patient outcomes;26-28 however, to our knowledge no articles are 
exploring how penalty enacting policies drive QIC participation.  
The HEN program’s new iterations should be researched as well. Launched in 2015, 
HEN 2.0 followed in the footsteps of the original HEN program. In version 2.0, CMS 




HENs’ original work.29 In 2016, CMS announced a further continuation of the program with 
the Hospital Improvement and Innovation Networks (HIIN). CMS awarded $347 million 
through 2019 to 16 organizations to improve on the work started by the HEN program.30 
However, there have been no known studies reviewing the effectiveness of these programs, 
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This study was the first known assessment of the HEN program since CMS’s 
inconclusive formal evaluation in 2014. There were several significant findings in this study. 
First, HEN participants had superior outcomes for CLABSIs and 30-day readmissions 
compared to nonparticipants before the HEN program commenced. Next, there was no 
evidence of the HEN participation’s effect on CLABSIs (p=.816). For 30-day readmission 
rates, the pre-post fixed effect regression coefficients for HEN participants were varied for 
HF (.018, p=.639), AMI (-.073, p=.032), and pneumonia (.097, p=.003). 
Limitations 
This study has several limitations for consideration. The first limitation is that critical 
access hospitals (CAHs) were omitted because CMS did not report the CLABSI data in 2011. 
Also, the readmission data were lacking for CAHs. Omitting these hospitals may have 
created sampling bias. CAHs may have experienced a more significant benefit in 
participating in the HEN program compared to larger hospitals. 
 Next, it is not known which hospitals dropped out of the HEN program. Some 
research shows that up to 30% of QIC participants drop out of similar programs.92 Similarly, 
this study did not have a variable to capture a hospital’s willingness to improve. The inability 
to quantify motivation is a standard limitation of quality improvement observational studies. 
Hospitals with a high motivation to improve might have been more likely to join a HEN. 
Therefore, a hospital’s desire to improve that leads to better outcomes, not necessarily the 




Omitted variable bias was also a concern with this study. Several quality 
improvement efforts were ongoing at the same time as the HEN program. These efforts 
included Meaningful Use, accountable care organizations, and bundled payments.84 
Initiatives focusing on cardiovascular readmissions started a few years before the HEN 
program.93,94 This study did not control for when hospitals joined these other programs.  
For the first study, the CLABSI SIR data were available only from 2011 through 
2014, which resulted in a short time-series panel. CLABSI SIR data before 2011 were not 
available in the Hospital Compare data archive. In 2015, the National Healthcare Safety 
Network updated how the CLABSI SIR was calculated.95 Therefore, we were unable to 
directly compare 2015 CLABSI SIR data with the other years in our panel. In the second 
study, the unique limitation was that we did not control for mortality rates, which were 
possibly correlated with readmission rates.96  
Future Research 
This study is the first known study to evaluate the HEN program apart from CMS’s 
formal evaluation. The study focused on two (CLABSIs and 30-day readmission rates) of the 
12 outcomes targeted by the HEN program. These two outcomes were chosen because the 
data were publicly available. Further research is needed on the other ten outcomes to 
determine if the results are similar to this study.  
Future QICs studies should evaluate using technology as a means to drive 
effectiveness. The QIC systematic review with a focus on methods did not mention the use of 
implementation software as an implementation tool. Using updated technologies may lead to 




Additional studies should also research monetary penalties for poor performance and 
participation QICs. For the past decade in the US, large QICs were preceded by penalties 
developed by policies. For instance, Meaningful Use issued penalties if providers did not 
adopt electronic health record (EHRs). However, simultaneously, the federal government 
created Regional Extension Centers (RECs) to aid EHR adoption. In 2012, the Hospital 
Readmissions Reduction Program began penalizing hospitals for readmissions. While at the 
same time, the HENs assisted hospitals with decreasing readmission rates. For example, in 
one qualitative study, several interviewees cited policy changes for joining a HEN.71 There 
were several studies on policy changes improving patient outcomes.97-99 However, no known 
articles are exploring how penalty enacting policies drive QIC participation. 
The HEN program’s new iterations should be researched and evaluated. Launched in 
2015, HEN 2.0 followed in the footsteps of the original HEN program. In version 2.0, CMS 
distributed $110 million for one year to 17 quality improvement organizations to continue the 
HENs’ original work.23 In 2016, CMS announced a further continuation of the program with 
the Hospital Improvement and Innovation Networks (HIIN). CMS awarded $347 million 
through 2019 to 16 organizations to improve on the work started by the HEN program.24 
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